We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 36

Cannabis at the Cutting Edge - Patents for a New U.S. Industry
  • Duane Morris LLP
  • USA
  • January 9 2018

When most people think of patented technologies, they think of cell phones, computers, and pharmaceuticals. What entrepreneurs in the cannabis


Attorney General Announces Creation of DOJ Opioid Fraud and Abuse Detection Unit
  • Duane Morris LLP
  • USA
  • August 3 2017

The creation of this new unit promises to yield an uptick in investigations and criminal prosecutions for violations of federal controlled-substances


House Passes the American Health Care Act to Repeal and Replace Affordable Care Act
  • Duane Morris LLP
  • USA
  • May 5 2017

Even though the repeal and replacement of the ACA seems on its way, the ACA still remains the law of the land. Employers should


Drug Quality and Security Act does not apply to veterinary compounding
  • Duane Morris LLP
  • USA
  • March 6 2015

While the Drug Quality and Security Act (DQSA) provided a new regulatory framework for compounded medications for use in human medicine, it does not


Supreme Court orders Ninth Circuit to revisit preemption ruling against generic OTC ibuprofen manufacturer
  • Duane Morris LLP
  • USA
  • November 2 2011

During its October 28, 2011, conference, the U.S. Supreme Court remanded to the Ninth Circuit its ruling denying federal preemption to a generic manufacturer of ibuprofen to be reassessed in light of the Court's Mensing decision last term.


Big win for drug companies under the New Jersey Product Liability Act
  • Duane Morris LLP
  • USA
  • October 4 2011

On September 29, 2011, in Bailey v. Wyeth, et al., a New Jersey appellate court affirmed summary judgment in favor of two Pfizer subsidiaries and Wyeth, Inc., dismissing claims for violations of New Jersey's Product Liability Act (PLA).


Pennsylvania District Court dismisses class action against pharmaceutical giant Johnson & Johnson
  • Duane Morris LLP
  • USA
  • July 26 2011

Judge Mary McLaughlin of the U.S. District Court for the Eastern District of Pennsylvania tossed a class action lawsuit last week after finding that the named plaintiffs lacked standing in In re McNeil Consumer Healthcare Litigation.


U.S. Supreme Court holds that state-law-based failure-to-warn claims are federally preempted against generic drug manufacturers
  • Duane Morris LLP
  • USA
  • June 23 2011

On June 23, 2011, the U.S. Supreme Court issued a decision in Pliva, Inc. v. Mensing,1 holding that state-law claims against generic drug manufacturers are federally preempted pursuant to the Supremacy Clause of the U.S. Constitution.


Measure creating pharmaceutical registry to undergo committee scrutiny
  • Duane Morris LLP
  • USA
  • June 9 2011

Legislation that would create a registry for pharmacists to cross reference prescriptions filled by other pharmacists will undergo hearings June 16 and June 23 in Harrisburg before the House Human Services Committee.


FDA: liquid OTC drugs with poorly labeled measuring devices may constitute misbranding
  • Duane Morris LLP
  • USA
  • May 10 2011

The FDA issued its final guidance relating to over-the-counter liquid drug products that are sold with measuring devices, such as spoons, cups or droppers.